MindWalk Holdings Corp.
NASDAQ:HYFT · NASDAQ Global Market
-$0.08 today
Vol 0.32M · Avg 0.33M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-128.0%
avg -48.2%
ROIC
-27.9%
avg -14.4%
ROA
-68.0%
avg -45.7%
Analysis
ROIC is currently the strongest return metric at -27.9% versus its period average of -14.4%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Richard Scott Areglado | Chief Financial Officer | $643,394.00 | — | 62 | — | — |
Jennifer Lynne Bath | Chief Executive Officer, President & Non-Independent Director | $628,494.00 | — | — | — | — |
Kari Graber | Vice President of Commercial Services | $237,541.00 | — | — | — | — |
Shuji Sato | Vice President of Innovative Solutions | $207,848.00 | — | — | — | — |
Dirk Van Hyfte | Chief Technology Officer | — | — | — | — | — |
Frederic Chabot | Head of Corporate Development | — | — | — | — | — |
Ingrid Brands | Chief Innovation & Strategy Officer | — | — | — | — | — |
Lori Anderson | Vice President of Brand Marketing and Creative | — | — | — | — | — |
Thomas Lynch | Chief Business Officer | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | N/A | N/A1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Analysis will appear once historical growth or forward estimates are available for this company.
Competitors
Peer companies in the same sector
ALX Oncology Holdings Inc.
NASDAQ:ALXO
$212.61M
Unicycive Therapeutics, Inc.
NASDAQ:UNCY
$155.81M
Repare Therapeutics Inc.
RPTX
$114.24M
Fortress Biotech, Inc.
NASDAQ:FBIO
$92.02M
CAMP4 Therapeutics Corporation
NASDAQ:CAMP
$89.00M
BeyondSpring Inc.
NASDAQ:BYSI
$64.56M
Fractyl Health, Inc. Common Stock
NASDAQ:GUTS
$61.36M
Clene Inc.
NASDAQ:CLNN
$60.20M
aTyr Pharma, Inc.
ATYR
$43.18M
Quince Therapeutics, Inc.
QNCX
$5.20M
Who manages HYFT?
MindWalk Holdings Corp. (HYFT) lists 9 active executives. The top listed executive is Jennifer Lynne Bath, Chief Executive Officer, President & Non-Independent Director.
Are HYFT insiders buying or selling?
Recent insider activity shows net selling of $10.15M.
Explore More
Continue the stock analysis
Jump to another research area for this company.